BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37635444)

  • 1. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site.
    Zarei S; Voss JS; Jin L; Jenkins SM; Bryce AH; Erickson LA; Bell DA; Kipp BR; Flotte TJ
    Int J Gynecol Pathol; 2020 Nov; 39(6):587-594. PubMed ID: 31567539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.
    van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA
    Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal melanoma in Denmark from 1980 to 2018: A population-based study based on genetic profile and survival.
    Yazdanfard NW; Mikkelsen LH; Behrendt N; Fuglsang K; Blaakær J; Hölmich LR; Frøding LP; Munch-Petersen HF; Heegaard S
    Gynecol Oncol; 2022 Apr; 165(1):53-59. PubMed ID: 35123773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients.
    Lally SE; Milman T; Orloff M; Dalvin LA; Eberhart CG; Heaphy CM; Rodriguez FJ; Lin CC; Dockery PW; Shields JA; Shields CL
    Ophthalmology; 2022 Jun; 129(6):679-693. PubMed ID: 35085662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
    Thielmann CM; Chorti E; Matull J; Murali R; Zaremba A; Lodde G; Jansen P; Richter L; Kretz J; Möller I; Sucker A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Paschen A; Livingstone E; Zimmer L; Schadendorf D; Hadaschik E; Ugurel S; Griewank KG
    Eur J Cancer; 2021 Dec; 159():113-124. PubMed ID: 34742158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Roles of
    Wróblewska JP; Dias-Santagata D; Ustaszewski A; Wu CL; Fujimoto M; Selim MA; Biernat W; Ryś J; Marszalek A; Hoang MP
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey.
    Mikkelsen LH; Larsen AC; von Buchwald C; Drzewiecki KT; Prause JU; Heegaard S
    APMIS; 2016 Jun; 124(6):475-86. PubMed ID: 27004972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
    Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
    BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic analysis of melanomas arising in acral sites.
    Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
    Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases.
    Zebary A; Jangard M; Omholt K; Ragnarsson-Olding B; Hansson J
    Br J Cancer; 2013 Aug; 109(3):559-64. PubMed ID: 23860532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary melanoma of the bladder: a case report and review of the literature.
    Quaquarini E; Saltalamacchia G; Tresoldi MM; Schmid M; Villani L; Bernardo A; Guarneri C; Camerota TC
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5122-5128. PubMed ID: 34486686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mucosal melanoma primary and metastatic cases with urogenital localization in our department].
    Szabó B; Szűcs M; Horváth A; Székely E; Pánczél G; Liszkay G; Holló P; Wikonkál N; Nyirády P
    Orv Hetil; 2019 Mar; 160(10):378-385. PubMed ID: 30829059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic NF1 deletions in sinonasal mucosal malignant melanoma.
    Riobello C; Casanueva Muruais R; Suárez-Fernández L; García-Marín R; Cabal VN; Blanco-Lorenzo V; Franchi A; Laco J; López F; Llorente JL; Hermsen MA
    Pigment Cell Melanoma Res; 2022 Jan; 35(1):88-96. PubMed ID: 34547192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant melanoma of the genitourinary tract: case series of a rare form of primary mucosal melanoma.
    Olapeju O; Shakesprere J; Boykin C; Bacaj P; Salkini M; Kolodney J
    Melanoma Manag; 2024 Feb; 10(4):MMT67. PubMed ID: 38577557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urethral Melanoma - Clinical, Pathological and Molecular Characteristics.
    Mano R; Hoeh B; DiNatale RG; Sanchez A; Benfante NE; Reznik E; Leitao MM; Shoushtari AN; Goh A; Donat SM; Herr HW; Bochner BH; Dalbagni G; Donahue TF
    Bladder Cancer; 2022; 8(3):291-301. PubMed ID: 36277327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
    Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
    APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
    Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
    Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.